Extract

The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degarelix.

Inclusion criteria

• Prostate cancer

Country

• Belgium
• Finland
• France
• Germany
• Montenegro
• Netherlands
• Romania
• Russian Federation
• Serbia
• United Kingdom

Links

• ictrp
• nct